CareDx, Inc.

CDNA Healthcare Diagnostics & Research

CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024.

Revenue
+39.3%
EPS
+1,133.3%
Free cash flow
−68.6%

Quarter to September 2026, against a year earlier

77.99 1.66 +2.17%
Market cap
$4.0B
P/E
30.9×
Fwd P/E
36.2×
Dividend yield
—
F-score
5/9
Altman Z
4.14
Beneish M
−3.36
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
ROE
33.04% 29.49% (2.36%) (6.27%)

+8 more TTM periods

Piotroski F-Score
7 8 6 5
ROA
23.96% 22.72% (1.82%) (4.72%)
ROIC
33.56% 130.06% (8.02%) (15.28%)
Return on Tangible Assets
61.45% 30.64% (3.67%) (10.66%)
Average Days of Receivables
35.03 27.39 39.42 40.97
Free Cash Flow per Share
1.15 1.65 1.27 0.65
Free Cash Flow
59.76 84.71 64.85 34.55
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026